EZL: 6-ethoxy-1,3-benzothiazole-2-sulfonamide
EZL is a Ligand Of Interest in 5TT3 designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5TT3_EZL_E_303 | 100% | 0% | 0.023 | 0.997 | 4.55 | 5.95 | 5 | 15 | 2 | 0 | 100% | 1 |
| 5TT3_EZL_G_303 | 99% | 0% | 0.027 | 0.996 | 4.56 | 5.96 | 5 | 15 | 0 | 0 | 100% | 1 |
| 5TT3_EZL_C_303 | 99% | 0% | 0.028 | 0.996 | 4.55 | 5.96 | 5 | 15 | 0 | 0 | 100% | 1 |
| 5TT3_EZL_F_302 | 99% | 0% | 0.03 | 0.996 | 4.56 | 5.97 | 5 | 15 | 1 | 0 | 100% | 1 |
| 5TT3_EZL_H_303 | 99% | 0% | 0.032 | 0.995 | 4.54 | 5.95 | 5 | 15 | 1 | 0 | 100% | 1 |
| 5TT3_EZL_A_303 | 99% | 0% | 0.033 | 0.995 | 4.56 | 5.97 | 5 | 15 | 3 | 0 | 100% | 1 |
| 5TT3_EZL_B_303 | 97% | 0% | 0.039 | 0.993 | 4.55 | 5.96 | 5 | 15 | 1 | 0 | 100% | 1 |
| 6QL2_EZL_A_306 | 99% | 15% | 0.029 | 0.996 | 1.84 | 1.85 | 6 | 9 | 0 | 0 | 100% | 1 |
| 3DCW_EZL_A_301 | 98% | 10% | 0.038 | 0.993 | 2.05 | 2.24 | 5 | 9 | 0 | 0 | 100% | 1 |
| 3DD0_EZL_A_301 | 95% | 6% | 0.045 | 0.99 | 2.03 | 3.04 | 6 | 12 | 0 | 0 | 100% | 1 |
| 5JN9_EZL_A_302 | 91% | 2% | 0.054 | 0.983 | 3.91 | 2.85 | 5 | 9 | 0 | 0 | 100% | 1 |
| 6BCC_EZL_A_302 | 90% | 17% | 0.052 | 0.984 | 1.97 | 1.59 | 3 | 3 | 0 | 0 | 96% | 1 |
